Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

GENVAX TECHNOLOGIES, LLC — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

GENVAX TECHNOLOGIES, LLC

via KEYS GROUP, LLC

1st Quarter (Jan 1 - Mar 31) · 2026Posted Apr 17, 2026Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: GENVAX TECHNOLOGIES, LLC
Description: Vaccine technologies
Location: Iowa · United States of America

Registrant

Firm: KEYS GROUP, LLC
Description: Government Affairs Consulting
Location: Shady Side, Maryland, United States of America

Lobbying activities

1 issue

Agriculture
Vaccine and facility approval
LobbyistsG CHANDLER KEYS iii · MICHAEL DAVID DUNLAP
TargetedSENATE · HOUSE OF REPRESENTATIVES · Agriculture, Dept of (USDA)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.